EcoDrugPlus

Vitamin D Receptor

Ensembl ID : ENSAMXG00000019854
Gene Symbol: VDR
3 Cross references
392 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSAMXG00000037562
Gene Symbol: LOC103029702
3 Cross references
191 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-2

Ensembl ID : ENSAMXG00000010460
Gene Symbol: LOC103035300
3 Cross references
204 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-4

Ensembl ID : ENSAMXG00000017573
Gene Symbol: LOC103035950
3 Cross references
203 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-1 Subunit

Ensembl ID : ENSAMXG00000041383
Gene Symbol: LOC103042501
3 Cross references
196 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-2 Subunit

Ensembl ID : ENSAMXG00000029460
Gene Symbol: LOC103039925
3 Cross references
249 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-2 Subunit

Ensembl ID : ENSAMXG00000040490
Gene Symbol: LOC103029856
3 Cross references
249 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSAMXG00000043635
Gene Symbol: LOC103022608
3 Cross references
168 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSAMXG00000041585
Gene Symbol: LOC103027859
2 Cross references
177 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSAMXG00000030494
Gene Symbol: LOC103023114
3 Cross references
181 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSAMXG00000011782
Gene Symbol: XDH
1 Cross references
212 Possible Orthologues:

Ensembl ID : ENSAMXG00000029657
Gene Symbol: -
Cross references: -
177 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).